Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epigenetic Therapy Before Prostatectomy in Men With Prostate Cancer
NCT06888102Phase 1Recruiting
- Start
- Apr 2026
- Primary completion
- Oct 2028
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in prostate cancer (PCa). Primary endpoints: Safety of Using Epigenetic Therapy at 2 Years, Toxicity of Using Epigenetic Therapy at 2 Years and 3 more. Started Apr 2026; status: recruiting.
02
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT06888102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06888102.